Fibrocell Science, Inc. (FCSC) Targeting Anti-Aging Market with Stem Cell Therapy
When you look in a mirror, do you see saggy cheek wrinkles running down at an angle from each side of your nose? If so, you’re on your way to understanding the significance of a Michigan biotech company called Fibrocell Science, Inc. (FCSC). Those wrinkles are called nasolabial fold wrinkles, and are considered the single most revealing indicator of your real age. Try it yourself. Use your hands to stretch your face back so that those sag wrinkles go away, and notice how much younger your face looks.
Developing an effective and affordable non-invasive anti-wrinkle treatment is cosmetic’s Holy Grail, and Fibrocell Science may have discovered the answer. The company has made major breakthroughs in developing a way to remove, regenerate, and reintroduce a person’s own fibroblasts, cells that contribute to the formation of connective tissue fibers that are critical to skin elasticity and tissue repair.
The patented process is called Fibrocell Therapy, and involves the generation and injection of azficel-T, a personalized treatment based upon the person’s own cells.
In controlled clinical studies, a significant improvement in the appearance of nasolabial fold wrinkles was observed after injecting azficel-T. Fibrocell even has a proposed brand name for the eventual product – laViv®. Given that the global anti-aging market could approach $275 billion by 2013, it’s a name worth remembering.